The FDA’s problem isn’t personnel — it’s enforcement
The resignation of FDA official Marty Makary has sparked media speculation, but the real issue lies in the agency's enforcement of regulations on flavored vapes. The FDA's inconsistent regulatory process has allowed a significant number of unregistered vape products to flood the market, posing risks to consumer safety. To protect youth and maintain legitimacy, the FDA must focus on thorough product reviews and enforce accountability among manufacturers.
- ▪Over 86% of the U.S. vape market consists of unregistered products, undermining the FDA's approval process.
- ▪The FDA's relaxed enforcement has allowed thousands of dangerous and unauthorized vaping products to proliferate in the U.S.
- ▪Only 45 flavored vape products are FDA-approved, while many cheap, unregulated disposables from China remain on the market.
Opening excerpt (first ~120 words) tap to expand
President Donald Trump’s FDA chief is out, but the reason behind it is not what many think. We must be careful not to learn the wrong lessons from Marty Makary’s resignation. The narrative around the resignation of former Food and Drug Administration official Makary, as reported in the media, implies he was pushed out for refusing to approve fruit-flavored vapes. In reality, the FDA reversed its strict stance against the product last week, and Makary’s departure involved several unrelated factors that marked his tenure, including mass layoffs and policy disputes with lawmakers and Trump. The media’s increased focus on political speculation is irresponsible. It distracts from the real issue at hand: the agency’s failure to implement regulations on the flavored vapes already on the market.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Washington Examiner.
Discussion
0 commentsMore from Washington Examiner
